EFFECT OF IMIDAPRIL IN DIPPER AND NONDIPPER HYPERTENSIVE PATIENTS: COMPARISON BETWEEN MORNING AND EVENING ADMINISTRATION

REFERENCES

• Boni E, Alicandri R, Fariello R, et al. Effect of enalapril on parasympathetic activity. Cardiovasc Drugs Ther. 1990; 4: 265–268
   PubMed Web of Science ®Google Scholar
• Champlain J, Yacine A, Blanc R L, et al. Effect of trandopril on the sympathetic tone and reactivity in systemic hypertension. Am J Cardiol. 1994; 73: 18C–25C
   PubMed Web of Science ®Google Scholar
• del Arco-Galan C, Suarez C. Nocturnal fall in arterial blood pressure in normotensive subjects: individual characteristic or the effect of daily activity. Medicina Clinica 1994; 102: 616–618
   PubMed Web of Science ®Google Scholar
• Demolis P, Annane D, Duhaze P, et al. Systemic regional and cerebral hemodynamic effect of a new angiotensin converting enzyme inhibitors. Fundam Clin Pharmacol. 1994; 8: 80–89
   PubMed Web of Science ®Google Scholar
• Ebata H, Hojo Y, Ikeda U, et al. Differential effects of an α1-blocker (doxazosin) on diurnal blood pressure variation in dipper and non-dipper type hypertension. Hypertens Res. 1995; 18: 125–130
   PubMedGoogle Scholar
• Higashi Y, Oshima T, Ozono R, et al. Nocturnal decline in blood pressure is attenuated by NaCl loading in salt-sensitive patients with essential hypertension. Hypertension 1997; 30: 163–167
   PubMed Web of Science ®Google Scholar
• Ijiri H, Kohno I, Yin D F, et al. Effects of imidapril hydrochloride on the autonomic nervous activity and the circadian blood pressure changes in essential hypertension. Ther Res. 1998; 19: 283–290
   Google Scholar
• Imai Y, Abe K, Nishiyama A, et al. Evaluation of the antihypertensive effect of barnidipine, a dihydropyridine calcium entry blocker, as determined by the ambulatory blood pressure level averaged for 24 h, daytime, and nighttime. Am J Hypertens. 1997; 10: 1415–1419
   PubMed Web of Science ®Google Scholar
• Ishii M, Takagi N. The antihypertensive effect and pharmacokinetics of a new angiotensin converting enzyme inhibitor, ACE/TA-6366(imidapril hydrochloride), in hypertensives associated with renal impairment [in Japanese]. Rinsyouiyaku 1992; 8: 299–313
   Google Scholar
• Jermendy G, Ferenczi J, Hernandez E, et al. Day-night blood pressure variation in normotensive and hypertensive NIDDM patients with asymptomatic autonomic neuropathy. Diabetes Res Clin Pract. 1996; 34: 107–114
   PubMed Web of Science ®Google Scholar
• Kahara K, Nishida W, Maguchi M, et al. Autonomic nervous function in non-dipper essential hypertensive subjects. Hypertension 1995; 26: 808–814
   PubMed Web of Science ®Google Scholar
• Kario K, Shimada K. Differential effects of amlodipine on ambulatory blood pressure in elderly hypertensive patients with different nocturnal reductions in blood pressure. Am J Hypertens. 1997; 10: 261–268
   PubMed Web of Science ®Google Scholar
• Kawasaki T, Ueno M, Uezono K, et al. Differences and similarities among circadian characteristics of plasma renin activity in healthy young women in Japan and United States. Am J Med. 1990; 68: 91–96
   Google Scholar
• Kohno I, Iwasaki H, Okutani M, et al. Administration-time-dependent effects of diltiazem on the 24-hour blood pressure profile of essential hypertension patients. Chronobiol Int. 1997; 14: 71–84
   PubMed Web of Science ®Google Scholar
• Lapinski M, Lewandowski J, Januszewicz A, et al. Hormonal profile of dipper and non-dipper patients with essential hypertension. J Hypertens. 1993; 5: S294–S295
   Google Scholar
• Lemmer B. Chronophramacology of hypertension. Ann N Y Acad Sci. 1995; 783: 242–253
   Google Scholar
• Morgan T, Anderson A, Jones E. The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night. J Hypertens. 1997; 15: 205–211
   PubMed Web of Science ®Google Scholar
• O'Brien E, Sheriden J, O'Malley K. Dippers and non-dippers. Lancet 1998; 2: 397
   Google Scholar
• Palatini P. Can an angiotensin-converting enzyme inhibitor with a short half-life effectively lower blood pressure for 24 hours. Am Heart J. 1992; 123: 1421–1425
   PubMed Web of Science ®Google Scholar
• Palatini P, Mos L, Motolese M, et al. Effect of evening versus morning benazepril on 24-hour blood pressure: a comparative study with continuous intraarterial monitoring. Int J Clin Pharmacol Therapy Toxicol. 1993; 31: 295–300
   PubMed Web of Science ®Google Scholar
• Petretta M, Bonaduce D, Marciano F, et al. Effect of 1 year of lisinopril treatment on cardiac autonomic control in hypertensive patients with left ventricular hypertrophy. Hypertension 1996; 27: 330–338
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Montanari L, Massari M, et al. Loss of nocturnal decline of blood pressure in hypertension due to chronic renal failure. Am J Hypertens. 1991; 4: 20–26
   PubMed Web of Science ®Google Scholar
• Rosansky S J, Menachery S J, Wagner C M, et al. The effect of sleep intervals on analysis of 24-h ambulatory blood pressure data. Am J Hypertens. 1995; 8: 672–675
   PubMed Web of Science ®Google Scholar
• Smolensky M H. Chronobiology and chronotherapeutics applications to cardiovascular medicine. Am J Hypertens. 1996; 9: 11S–21S
   PubMed Web of Science ®Google Scholar
• Smolensky M H, Portaluppi F. Ambulatory blood pressure monitoring. Application to clinical medicine and antihypertension medical trial. Ann N Y Acad Sci. 1995; 783: 278–294
   Web of Science ®Google Scholar
• Suzuki S, Mori M, Kushino S. Circadian blood pressure variation and hemodynamic effects of a angiotensin converting enzyme inhibitor, ACE/TA-6366 (imidapril hydrochloride), in patients with essential hypertension—single oral administration and 7 days repeated oral administration [in Japanese]. Rinsyoutokenkyu 1992; 69: 636–648
   Google Scholar
• Tamura K, Kohno I, Tsuruta I, et al. Chronobiologic assessment of antihypertensive therapy. Ann 1st Super Sanita 1993; 29: 693–704
   PubMedGoogle Scholar
• Unger T, Ganten D, Lang R E, et al. Persistent tissue converting enzyme inhibition following chronic treatment with Hoe 498 and MK 421 in spontaneously hypertensive rat. J Cardiovasc Pharmacol. 1985; 7: 36–41
   PubMed Web of Science ®Google Scholar
• Valles P M, Matas S M, Bronsoms A J, et al. Quinapril ACE inhibitor effects on adrenergic parameters in moderate essential hypertension. Kidney Int. 1996; 55: s104–s106
   Google Scholar
• Verdecchia P, Schillaci G, Guerrieri M, et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990; 81: 528–536
   PubMed Web of Science ®Google Scholar
• White W B, Black H R, Weber M A, et al. Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product. Am J Cardiol. 1998; 81(4)424–431
   PubMed Web of Science ®Google Scholar
• Witte K, Weisser K, Neubeck M, et al. Cardiovascular effects, pharmacokinetics, and converting enzyme inhibition of enalapril after morning versus evening administration. Clin Pharmacol Ther. 1993; 54: 177–186
   PubMed Web of Science ®Google Scholar
• Zannad F. Duration of action of angiotensin converting enzyme inhibitors. Am J Hypertens. 1995; 8: S75–S81
   Web of Science ®Google Scholar
• Zannad F, Matzinger A, Larche J. Trough/peak ratios of once daily angiotensin converting enzyme inhibitors and calcium antagonists. Am J Hypertens. 1996; 8: 633–643
   Google Scholar